Lidocaine 2% without vessel constrictor

DRUG3 trials

Sponsors

Federal University of São Paulo, University of Louisville, Liaquat National Hospital & Medical College

Conditions

Neurogenic BladderOveractive BladderOveractive Bladder SyndromePainPost-operative PainPost-operative Pain ControlSclerodermaUrge Incontinence

Phase 2

Effectiveness and Safety of Lidocaine for Scleroderma

CompletedNCT00740285

Federal University of São PauloScleroderma

Start: 2004-04-30End: 2007-04-30Updated: 2008-08-22

Phase 3

Effect of Lidocaine in Reducing Opioids Requirement in Day Care Surgery

CompletedNCT06717672

Liaquat National Hospital & Medical CollegePain, Post-operative Pain, Post-operative Pain Control

Start: 2023-11-05End: 2024-05-10Updated: 2024-12-10

Phase 4

Optimal Intravesical Lidocaine Volume for Pain Relief During Office Intra-detrusor Onabotulinum Toxin a Injections

Not yet recruitingNCT06695585

University of LouisvilleNeurogenic Bladder, Overactive Bladder, Overactive Bladder Syndrome +3

Start: 2024-12-01End: 2025-12-01Target: 36Updated: 2024-11-19